US FDA Issues Final Guidance On Cybersecurity In Medical Devices

Maryland: The FDA has issued the final guidance Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket SubmissionsThe guidance replaces Content of Premarket Submissions for Management of Cybersecurity in Medical Devices, issued on October 2, 2014.

This document provides recommendations on medical device cybersecurity considerations, device design and labeling, and what information to include in premarket submissions. “These recommendations are intended to promote consistency, facilitate efficient premarket review and help ensure that marketed medical devices are sufficiently resilient to cybersecurity threats,” the FDA states.

The guidance emphasizes that cybersecurity is part of device safety and the quality system requirements found in 21 CFR Part 820, which may be relevant at the premarket stage, postmarket stage or both. It provides recommendations on:

 

  • How connected devices should be tested and validated against breaches that affect multiple connected devices.
  • Provides labeling recommendations for devices with cybersecurity risks.
  • Recommends that companies develop cybersecurity management plans that communicate how they will identify and communicate postmarket vulnerabilities in accordance with 21 CFR 820.100.
  • Recommends that manufacturers provide an updateability and patchability view that describes the end-to-end process that permits software updates and patches to be provided/deployed once the device is in the field.

The guidance recommends that manufacturers use device design processes such as those described in the QS regulation to support secure product development and maintenance. But, to preserve flexibility, they may use other existing frameworks that satisfy the QS regulation and align with FDA’s recommendations for using a Security Product Development Framework (SPDF). Possible frameworks to consider include, but are not limited to, the medical device-specific framework that can be found in the Medical Device and Health IT Joint Security Plan (JSP) 30 and IEC 81001-5-1 or in ANSI/ISA 62443-4-1 Security for industrial automation and control systems Part 4- 1: Product security development life-cycle requirements.

Related Posts

CCRAS committee reviews research programmes and future initiatives to strengthen Ayurveda research

The 106th meeting of the Internal Finance Committee (IFC) of the Central Council for Research in Ayurvedic Sciences (CCRAS) was held at the Regional Ayurveda Research Institute (RARI), Itanagar. The…

Maharashtra FDA increases medicine and cosmetics testing, flags 108 samples as non-compliant

Maharashtra’s Food and Drug Administration (FDA) has significantly increased laboratory testing of medicines and cosmetics, with 3,020 samples collected and 2,112 examined between June and August 2026. Of the drug…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CCRAS committee reviews research programmes and future initiatives to strengthen Ayurveda research

CCRAS committee reviews research programmes and future initiatives to strengthen Ayurveda research

Maharashtra FDA increases medicine and cosmetics testing, flags 108 samples as non-compliant

Maharashtra FDA increases medicine and cosmetics testing, flags 108 samples as non-compliant

Assam: Drug inspector couple dismissed from service over bribery, disproportionate assets cases

Assam: Drug inspector couple dismissed from service over bribery, disproportionate assets cases

Health ministry strengthens allied and healthcare education and professional standards

Health ministry strengthens allied and healthcare education and professional standards

Siddhanta Super Speciality Hospital’s registration, licence cancelled in Bhopal: CMHO inspection finds 19 serious lapses from emergency to ICU; dialysis rules violated

Siddhanta Super Speciality Hospital’s registration, licence cancelled in Bhopal: CMHO inspection finds 19 serious lapses from emergency to ICU; dialysis rules violated

Chemist selling narcotics held, medical store sealed

Chemist selling narcotics held, medical store sealed